Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,529 | -46,787 | -30,043 | -84,689 | -56,018 |
| Depreciation Amortization | 808 | 1,216 | 653 | -3,236 | -2,831 |
| Accounts receivable | 1,530 | 67 | 160 | 2,716 | 1,246 |
| Accounts payable and accrued liabilities | -2,285 | 382 | -1,341 | 1,229 | 8,256 |
| Other Working Capital | -352 | -1,463 | -4,275 | -14,057 | -10,289 |
| Other Operating Activity | 1,004 | 1,110 | 5,713 | 21,592 | 10,515 |
| Operating Cash Flow | $-42,824 | $-45,475 | $-29,133 | $-76,445 | $-49,121 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,743 | 27,206 | 28,792 | 49,468 | 17,882 |
| PPE Investments | 1,000 | 1,000 | N/A | N/A | N/A |
| Investing Cash Flow | $30,743 | $28,206 | $28,792 | $49,468 | $17,882 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 109 | 79 | 79 | 542 | 541 |
| Financing Cash Flow | $109 | $79 | $79 | $542 | $541 |
| Exchange Rate Effect | 80 | 129 | N/A | -116 | -29 |
| Beginning Cash Position | 84,717 | 84,717 | 84,717 | 111,268 | 111,268 |
| End Cash Position | 72,825 | 67,656 | 84,455 | 84,717 | 80,541 |
| Net Cash Flow | $-11,892 | $-17,061 | $-262 | $-26,551 | $-30,727 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,824 | -45,475 | -29,133 | -76,445 | -49,121 |
| Free Cash Flow | -42,824 | -45,475 | -29,133 | -76,445 | -49,121 |